RE: BRCA1 and BRCA2 Gene Mutations and Colorectal Cancer Risk: Systematic Review and Meta-analysis.
作者信息
Katona Bryson W, Stadler Zsofia K, Robson Mark E, Domchek Susan M
机构信息
Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
Clinical Genetics Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY.
出版信息
J Natl Cancer Inst. 2019 May 1;111(5):522-523. doi: 10.1093/jnci/djz012.
Abstract
摘要
相似文献
1
RE: BRCA1 and BRCA2 Gene Mutations and Colorectal Cancer Risk: Systematic Review and Meta-analysis.主题：BRCA1和BRCA2基因突变与结直肠癌风险：系统评价与荟萃分析
J Natl Cancer Inst. 2019 May 1;111(5):522-523. doi: 10.1093/jnci/djz012.
2
RE: BRCA1 and BRCA2 Gene Mutations and Colorectal Cancer Risk: Systematic Review and Meta-Analysis.
J Natl Cancer Inst. 2020 Apr 1;112(4):426-427. doi: 10.1093/jnci/djz162.
3
Incidence of colorectal cancer in BRCA1 and BRCA2 mutation carriers: results from a follow-up study.BRCA1 和 BRCA2 基因突变携带者结直肠癌的发病率：一项随访研究的结果。
Br J Cancer. 2014 Jan 21;110(2):530-4. doi: 10.1038/bjc.2013.741. Epub 2013 Nov 28.
4
BRCA1 and BRCA2 Gene Mutations and Colorectal Cancer Risk: Systematic Review and Meta-analysis.BRCA1 和 BRCA2 基因突变与结直肠癌风险：系统评价和荟萃分析。
J Natl Cancer Inst. 2018 Nov 1;110(11):1178-1189. doi: 10.1093/jnci/djy148.
5
6
Risk of colorectal cancer associated with BRCA1 and/or BRCA2 mutation carriers: systematic review and meta-analysis.BRCA1 和/或 BRCA2 基因突变携带者结直肠癌发病风险的系统评价和荟萃分析。
Br J Surg. 2020 Jul;107(8):951-959. doi: 10.1002/bjs.11603. Epub 2020 Apr 16.
7
BRCA1 and BRCA2 mutations and the risk for colorectal cancer.BRCA1和BRCA2基因变异与结直肠癌风险
Clin Genet. 2015 May;87(5):411-8. doi: 10.1111/cge.12497. Epub 2014 Oct 21.
8
The association of BRCA1 and BRCA2 mutations with prostate cancer risk, frequency, and mortality: A meta-analysis.BRCA1 和 BRCA2 突变与前列腺癌风险、频率和死亡率的关联：一项荟萃分析。
Prostate. 2019 Jun;79(8):880-895. doi: 10.1002/pros.23795. Epub 2019 Mar 22.
9
Phenotypic characteristics of colorectal cancer in BRCA1/2 mutation carriers.BRCA1/2 突变携带者结直肠癌的表型特征。
Eur J Hum Genet. 2018 Mar;26(3):382-386. doi: 10.1038/s41431-017-0067-1. Epub 2018 Jan 10.
10
Assessment of the prevalence of de novo mutations in the BRCA1 and BRCA2 genes.评估BRCA1和BRCA2基因中新生突变的发生率。
Clin Genet. 2011 Jul;80(1):97-8. doi: 10.1111/j.1399-0004.2011.01691.x.
引用本文的文献
1
Case Report: Influence of BRCA1 germline mutation on treatment-related morbidity of a non-seminomatous germ cell tumor patient.病例报告：BRCA1 种系突变对非精原细胞性生殖细胞肿瘤患者治疗相关发病率的影响。
Front Oncol. 2025 May 30;15:1579574. doi: 10.3389/fonc.2025.1579574. eCollection 2025.
2
Efficacy of olaparib in advanced cancers with germline or somatic mutations in BRCA1, BRCA2, CHEK2 and ATM, a Belgian Precision tumor-agnostic phase II study.比利时一项基于精准肿瘤的 II 期、不限癌种的临床试验，评估奥拉帕利治疗携带有胚系或体细胞 BRCA1/2、CHEK2 或 ATM 基因突变的晚期癌症患者的疗效。
ESMO Open. 2023 Dec;8(6):102041. doi: 10.1016/j.esmoop.2023.102041. Epub 2023 Oct 16.
3
Risk Factors for the Diagnosis of Colorectal Cancer.结直肠癌诊断的危险因素。
Cancer Control. 2022 Jan-Dec;29:10732748211056692. doi: 10.1177/10732748211056692.
4
Spectrum of germline cancer susceptibility gene mutations in Turkish colorectal cancer patients: a single center study.土耳其结直肠癌患者种系癌症易感性基因突变谱：一项单中心研究。
Turk J Med Sci. 2020 Jun 23;50(4):1015-1021. doi: 10.3906/sag-2002-46.
本文引用的文献
1
BRCA1 and BRCA2 Gene Mutations and Colorectal Cancer Risk: Systematic Review and Meta-analysis.BRCA1 和 BRCA2 基因突变与结直肠癌风险：系统评价和荟萃分析。
J Natl Cancer Inst. 2018 Nov 1;110(11):1178-1189. doi: 10.1093/jnci/djy148.
2
A counseling framework for moderate-penetrance colorectal cancer susceptibility genes.中度显性遗传性结直肠癌易感基因的咨询框架
Genet Med. 2018 Nov;20(11):1324-1327. doi: 10.1038/gim.2018.12. Epub 2018 Mar 1.
3
Genetic factors and colorectal cancer in Ashkenazi Jews.阿什肯纳兹犹太人的遗传因素与结直肠癌
Fam Cancer. 2004;3(3-4):215-21. doi: 10.1007/s10689-004-9547-x.
4
A systematic review and meta-analysis of familial colorectal cancer risk.家族性结直肠癌风险的系统评价与荟萃分析。
Am J Gastroenterol. 2001 Oct;96(10):2992-3003. doi: 10.1111/j.1572-0241.2001.04677.x.
Zotero 插件